# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-284583
Filing Date
2022-11-14
Accepted
2022-11-14 16:15:40
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | d383755d10q.htm iXBRL | 10-Q | 1143950
2 | EX-31.1 | d383755dex311.htm | EX-31.1 | 10546
3 | EX-31.2 | d383755dex312.htm | EX-31.2 | 10916
4 | EX-32.1 | d383755dex321.htm | EX-32.1 | 4745
5 | EX-32.2 | d383755dex322.htm | EX-32.2 | 4715
| Complete submission text file | 0001193125-22-284583.txt |  | 5031926

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | abos-20220930.xsd | EX-101.SCH | 45643
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | abos-20220930_cal.xml | EX-101.CAL | 38191
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | abos-20220930_def.xml | EX-101.DEF | 217468
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | abos-20220930_lab.xml | EX-101.LAB | 324244
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | abos-20220930_pre.xml | EX-101.PRE | 271717
52 | EXTRACTED XBRL INSTANCE DOCUMENT | d383755d10q_htm.xml | XML | 805064

Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40551 | Film No.: 221385551
SIC: 2836 Biological Products, (No Diagnostic Substances)